PMA device
Activa and Percept Deep Brain Stimulation Therapy System
Medtronic, Inc. · Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY, Class III) · First FDA decision Apr 12, 2000, newest Dec 23, 2024Essential tremorParkinson's disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
71
Naming "Activa"
MAUDE reports
25,272
Brand "Activa", since 2015
PubMed studies
456
Mentioning "Activa"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Activa and Percept Deep Brain Stimulation Therapy System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Activa and Percept Deep Brain Stimulation Therapy SystemPMA supplement
P960009-S486 · Decided Dec 23, 2024 · 84 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implanted, for parkinsonian tremor (MHY) · Neurology & Neurosurgery
- ACTIVA IMPLANTABLE NEUROSTIMULATORSPMA supplement
P960009-S090 · Decided Apr 22, 2011 · 263 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implanted, for parkinsonian tremor (MHY) · Neurology & Neurosurgery
- ACTIVA TREMOR CONTROL THEREAPY SYSTEMPMA supplement
P960009-S019 · Decided Dec 31, 2001 · 181 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implanted, for parkinsonian tremor (MHY) · Neurology & Neurosurgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- External Upper Limb Tremor Stimulator TherapyLocal determinationIn effectL39591CGS Administrators, LLCUpdated Feb 16, 2024
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Activa", any status and sponsor, newest update first.
Bezmialem Vakif UniversityAcademic, hospital or other
NCT07547904 · 34 participants (planned) · Start Feb 5, 2026 · Primary completion Nov 30, 2027
Device: Activa BioACTIVE Bulk Flow; Filtek Z250 · For: Dental Caries
Sites: Istanbul, Turkey (Türkiye)
- Deep Brain Stimulation Surgery for Focal Hand DystoniaActive, not recruiting
National Institute of Neurological Disorders and Stroke (NINDS)NIH
NCT02911103 · 5 participants · Start Jan 17, 2018 · Primary completion Feb 2, 2029
Device: Medtronic Activa Rechargeable System · For: Dystonia; Focal Dystonia; Musician's Dystonia
Sites: Bethesda, Maryland
National Institute of Neurological Disorders and Stroke (NINDS)NIH
NCT01581580 · 200 participants (planned) · Start Aug 17, 2011 · Primary completion Dec 1, 2029
Device: Medtronic Activa Tremor Control System · For: Parkinson's Disease; Essential Tremor; Dystonia
Sites: Bethesda, Maryland
68 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Activa", and for the whole product code for context.
This brand
25,272 reports: 15,816 malfunction, 9,323 injury, 133 death
Whole product code MHY
39,013 reports: 20,330 malfunction, 18,367 injury, 312 death
Newest reports for this brand
- ACTIVAMalfunction
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18460 · Received Oct 29, 2026 · Event dated Oct 21, 2026
Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Device problem as coded: Intermittent Continuity
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ACTIVAInjury
2182207-2026-03058 · Received Oct 29, 2026
Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Device problem as coded: Malposition of Device
Patient problem as coded: Insufficient Information
- ACTIVAInjury
MEDTRONIC PUERTO RICO OPERATIONS CO.
3004209178-2026-18357 · Received Oct 28, 2026 · Event dated Oct 23, 2026
Device type: Stimulator, Electrical, Implanted, For Essential Tremor (PJS)
Device problem as coded: Failure to Deliver Energy
Patient problem as coded: Shaking/Tremors
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted, for parkinsonian tremorOpen, Classified
Z-2240-2026 · Started May 13, 2026 · Posted by FDA May 28, 2026
Reason given: A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
- Medtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimulator, electrical, implanted, for parkinsonian tremorOpen, Classified
Z-2241-2026 · Started May 13, 2026 · Posted by FDA May 28, 2026
Reason given: A limited number of Pocket Adaptor Kits, Model 64001 and 64002, are labeled with incorrect Use-By-Dates.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
Z-0206-2025 · Started Sep 24, 2024 · Posted by FDA Oct 23, 2024
Reason given: A limited number of Percept RC Implantable Neurostimulators (INS), Model B35300 will not be able to communicate with the A610 DBS Clinician Programmer Application upon use and an "Invalid Device" message will appear.
Cause as FDA categorized it: Under Investigation by firm · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Tremor (MHY)
17 more recall records with a free account
Published research
The most relevant PubMed records for "Activa"[tiab]. The summary above synthesizes these.
- Thyroid cancer.
Reverter JL · Med Clin (Barc) · 2025Review
- ACTIVA: realistic single-cell RNA-seq generation with automatic cell-type identification using introspective variational autoencoders.
Heydari AA, Davalos OA, Zhao L, et al. · Bioinformatics · 2022Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Bio-Inductive Materials in Direct and Indirect Pulp Capping-A Review Article.
Kunert M, Lukomska-Szymanska M · Materials (Basel) · 2020Review
- Physiotherapy, movement, and action.
Nicholls DA, Vieira A · Physiother Theory Pract · 2023
- Vita activa in biotechnology: what we do with fungi and what fungi do with us.
Weinhold M, Mast-Gerlach E, Meyer V · Fungal Biol Biotechnol · 2017Editorial
- One-Year Clinical Performance of Activaࡊ Bioactive-Restorative Composite in Primary Molars.
Lardani L, Derchi G, Marchio V, et al. · Children (Basel) · 2022
- Effects of Serial Sessions of Activa Mask for the Treatment of Meibomian Gland Dysfunction.
Vigo L, Pellegrini M, D'Angelo S, et al. · Ophthalmol Ther · 2023
- An active break program (ACTIVA-MENTE) at elementary schools in Chile: study protocol for a pilot cluster randomized controlled trial.
Reyes-Amigo T, Ibarra-Mora J, Aguilar-Farías N, et al. · Front Public Health · 2023Clinical Trial Protocol, Research Support, Non-U.S. Gov't
- Secondary caries adjacent to restorative materials.
Conner C, Hicks J, Garcia-Godoy F · Am J Dent · 2025Randomized Controlled Trial
- Current management of small renal masses.
Martínez Rodríguez C, Tardáguila de la Fuente G, Villanueva Campos AM · Radiologia (Engl Ed) · 2020Review
- ACTIVA-Senior: Study Design and Protocol for a Preliminary Multidomain Outdoor Intervention Promoting Healthy Aging and Mitigating Psycho-Physiological Decline.
García-Llorente AM, Vaquero-Cristóbal R, Casimiro-Andújar AJ, et al. · Healthcare (Basel) · 2025
- The Cytotoxicity and Genotoxicity of Bioactive Dental Materials.
Kunert M, Rozpedek-Kaminska W, Galita G, et al. · Cells · 2022Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MHY.
- Activa Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2025
- Infinity family of DBS IPGsAbbott Medical · PMA 2021
- Medtronic Activa Tremor Control SystemMedtronic, Inc. · PMA 2023
- Deep Brain Stimulation (DBS) Neurostimulation SystemAbbott Medical · PMA 2025
- Brio Neurostimulation SystemAbbott Medical · PMA 2024
- Deep Brain Stimulation (DBS) Therapy for EpilepsyMedtronic, Inc. · PMA 2019
- Liberta RC DBS IPGAbbott Medical · PMA 2025
- Activa, Percept and SenSight Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.